Pfizer has announced that it will be testing a third dose of its coronavirus vaccine to determine if it will offer better protection against variants of the virus.
“We believe that the third dose will raise the antibody response 10- to 20-fold," Pfizer CEO Albert Bourla said in an interview with NBC News.
In-depth coverageas the midterms
take shape.
Follow the latest midterm news, analysis, and expert perspectives with unlimited access.
See Subscription Options
Already a member? Log in
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.